Clinical Trials Logo
  1. Home
  2. Bowel Preparation
  3. NCT03992365

Study of the Efficacy and Safety of Quiklean® and Klean-Prep With Dulcolax® for the Bowel Preparation Prior to Colonoscopy

Bowel Preparation Clinical Trial

Official title:
A Prospective, Randomized, Evaluator Blind, Active-Controlled, Parallel Study of the Efficacy and Safety of Quiklean® and Klean-Prep With Dulcolax® for the Bowel Preparation Prior to Colonoscopy

Clinical Trial Summary

The objective is to demonstrate that investigational drug, Quiklean®, is not inferior to standard comparator, Klean-Prep with Dulcolax®, with respect to the overall quality of bowel preparation in subjects undergoing colonoscopy.

Clinical Trial Description

This will be a randomized, evaluator blind, active-controlled, parallel study to compare the safety and efficacy of investigational drug (Quiklean®) with standard comparator (Klean-Prep with Dulcolax®) in subjects undergoing bowel preparation for colonoscopy. This study will be conducted in two arms:

1. Group A: Quiklean® (32 tablets)

2. Group B: 2 sachets of Klean-Prep with 1 tablet of Dulcolax® The study will be consist of 4 clinical visits. Subjects will come to the clinics at Visit 1 (the start of the screening), Visit 2 (randomization), and Visit 3 (colonoscopy visit), and Visit 4 (follow-up visit) according to the pre-defined schedule.

After the inform consent is obtained from the subject, the designated assessment will be performed. If the eligibility criteria has been met, the subjects will be randomly assigned with a 1:1 (Group A:B) and scheduled to a colonoscopy. The colonoscopy visit should be arranged within 10 days after screening visit and randomization. Subjects are instructed how to take study medication, and standard dietary instructions for each group are identical.

After bowel preparation, the colonoscopy will be performed in the morning by the experienced colonoscopist, and the entire process of colonoscopy will be simultaneously recorded by video. The quality of bowel cleansing in video will be rated by an independent blinded colonoscopist after the completion of colonoscopy.

The modified Aronchick scale for the primary efficacy endpoint and the Ottawa scale, and subject's responses to the acceptability and tolerability for the secondary efficacy endpoint will be rated and collected. The safety laboratory examinations from the blood sample, solicited events from the start of administration of study medications before colonoscopy, and treatment-emergent adverse events will be also recorded. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03992365
Study type Interventional
Source Universal Integrated Corp.
Contact
Status Completed
Phase Phase 3
Start date June 10, 2019
Completion date January 15, 2020
View Details
See also
  Status Clinical Trial Phase
Completed NCT04101097 - Training and Validation of Models of Factors to Predict Inadequate Bowel Preparation Colonoscopy
Completed NCT05670470 - A Prospective, Randomized, Investigator-blinded, Parallel, Multi-center, Phase 3 Trial Phase 3
Not yet recruiting NCT02536729 - Evaluation of the Quality of Life of Patients Requiring Intestinal Cleansing Using Oral Medications to Imaging Procedure by Patient Reported Outcome N/A
Completed NCT02093156 - A Predictive Score Identifies Patients With Inadequate Bowel Preparation for Colonoscopy N/A
Completed NCT00831064 - A Trial of Four Different Bowel Cleansing Regimens Prior to Colonoscopy N/A
Completed NCT06141122 - The Colonoscopy Booklet:Effect of a Recipe Resource on Quality of Colonoscopy Bowel Preparation and Patient Experience N/A
Recruiting NCT05137145 - Effect and Safety of Polyethylene Glycol Combined With Linaclotide on Colon Cleansing for Patients With Chronic Constipation N/A
Recruiting NCT04591145 - Multi-center Validation of a Deep Learning Based Bowel Preparation Evaluation System
Completed NCT04605432 - FFI and PR Could Improve Bowel Cleansing. N/A
Completed NCT05088408 - Comparative Study Between Colonoscopy Bowel Preparation With Clear Liquids, With and Without Two Servings of High Energy Nutritional Supplement Phase 4
Withdrawn NCT04087265 - Accuracy of Trans-abdominal Ultrasound in Evaluating Bowel Preparation Adequacy Before Colonoscopy N/A
Recruiting NCT06051955 - Evaluation of an Oral Sodium Sulfate Solution for Patients With Prior Difficult or Incomplete Cleansing N/A
Recruiting NCT05609591 - Three Dietary Regimens in Pre-colonoscopic Bowel Preparation in Children N/A
Completed NCT02979223 - Combination Method Using Sodium Picosulfate and Magnesium Citrate and PEG With Ascorbic Acid for Bowel Preparation Phase 2
Completed NCT02290093 - Bowel Preparation for Colonoscopy in the Elderly Phase 4
Completed NCT01513096 - Efficacy of Prokinetics With Split Dose of PEG in Morning Colonoscopic Bowel Preparation Phase 3
Completed NCT03704571 - A Predictive Model for Inadequate Bowel Preparation N/A
Recruiting NCT06438237 - Validation of a Prediction Model for Inadequate Bowel Preparation
Recruiting NCT05041283 - Impact of Artificial Intelligence-based Patient Reinforcement on Quality of Colonoscopy N/A
Recruiting NCT02761317 - Optimal Bowel Preparation Regimen in Patients With Colorectal Surgery Phase 4